Patrick Mahaffy, Clovis CEO (Kathryn Scott Osler/The Denver Post via Getty Images)

May 6, 2022 01:28 PM EDT

That big R&D PARP win Clovis CEO Mahaffy touted a few weeks ago? The FDA isn't buying it

Once again, you’ll have to go to the fine print in an SEC filing to find the bad news that has been steadily killing Clovis …

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE LOG IN

TRENDING NOW

That big R&D PARP win Clo­vis CEO Ma­haffy tout­ed a few weeks ago? The FDA is­n't buy­ing it